What is the 2032 estimate for the D-dimer testing market?

The global market for d-dimer testing was over USD 1 billion in 2022 and will reach more than USD 2 billion by 2032.

Why is the ELISA testing method widely used in the D-dimer testing?

The enzyme-linked immunosorbent assay (ELISA) segment will record more than USD 700 million by 2032 as they are highly sensitive and capable of detecting even low levels of D-dimer in blood samples.

What are the factors driving the U.S. d-dimer testing market growth?

The U.S. d-dimer testing industry accounted for more than USD 450 billion in 2022 and will grow to USD 615 billion by 2032 owing to the affordability of d-dimer testing among the target population base and ongoing technological developments.

Which are the top companies in d-dimer testing sector?

Abbott Laboratories, BioMedica Diagnostics, biom

D-dimer Testing Market Share

Report ID: GMI5972

Published Date: June 2023

Report Format: PDF

Download Free PDF

D-dimer Testing Market Share

Some of the notable key industry players operating in the d-dimer testing market include :

Abbott Laboratories
BioMedica Diagnostics
biomérieux SA
Diazyme Laboratories Inc. (General Atomics)
FHoffmann-La Roche Ltd.
HORIBA Ltd.
Quidel Corporation
Sekisui Diagnostics LLC (Sekisui Chemical Co. Ltd.)
Siemens Healthcare GmbH
Thermo Fisher Scientific Inc.
Unbound Medicine Inc
Werfen

These market participants are implementing various growth strategies such as collaborations, partnerships, acquisitions & mergers, and new product development and launches to strengthen testing method offerings as well as gain a competitive edge over others.

Authors: Mariam Faizullabhoy ,

Frequently Asked Question(FAQ) :

What is the 2032 estimate for the D-dimer testing market?: The global market for d-dimer testing was over USD 1 billion in 2022 and will reach more than USD 2 billion by 2032.
Why is the ELISA testing method widely used in the D-dimer testing?: The enzyme-linked immunosorbent assay (ELISA) segment will record more than USD 700 million by 2032 as they are highly sensitive and capable of detecting even low levels of D-dimer in blood samples.
What are the factors driving the U.S. d-dimer testing market growth?: The U.S. d-dimer testing industry accounted for more than USD 450 billion in 2022 and will grow to USD 615 billion by 2032 owing to the affordability of d-dimer testing among the target population base and ongoing technological developments.
Which are the top companies in d-dimer testing sector?: Abbott Laboratories, BioMedica Diagnostics, biom

Related Reports

Authors: Mariam Faizullabhoy ,

Buy Now

Single User: $4,123 $4,850

15% off

Multi User: $4,840 $6,050

20% off

Enterprise User: $5,845 $8,350

30% off

Buy now

Premium Report Details

Base Year: 2022

Companies covered: 12

Tables & Figures: 279

Countries covered: 32

Pages: 200

Download Free PDF

D-dimer Testing Market Share

D-dimer Testing Market Share

Premium Report Details

Industries

Information

Link

Global Headquarters